SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001651308-22-000003
Filing Date
2022-01-10
Accepted
2022-01-10 07:38:46
Documents
13
Period of Report
2022-01-06
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bgne-20220106.htm   iXBRL 8-K 52462
2 EX-99.1 ax10jan2022xex991xtislenmp.htm EX-99.1 41502
  Complete submission text file 0001651308-22-000003.txt   248834

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bgne-20220106.xsd EX-101.SCH 1996
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bgne-20220106_lab.xml EX-101.LAB 25214
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bgne-20220106_pre.xml EX-101.PRE 13249
7 EXTRACTED XBRL INSTANCE DOCUMENT bgne-20220106_htm.xml XML 12328
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 981209416 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37686 | Film No.: 22519711
SIC: 2834 Pharmaceutical Preparations